Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Can This Cardiac King Find Its Nerve?

St. Jude Medical (NYSE: STJ  ) and its investors have weathered quite a storm in the medical device industry. The company has pushed past falling sales and earnings through 2013 to post remarkable gains over the past 52 weeks. Still, growth has remained elusive in some of St. Jude's top business divisions. The company has turned to one of its smaller businesses with big potential for its future: neuromodulation.

St. Jude's neuromodulation business made up less than 10% of its total sales through the nine months of 2013 that ended in September, but this division's managed to eke out minor growth despite slips at St. Jude's larger units. The company's banking on a new trial of its Prodigy next-generation neurostimulation device to help boost growth in the near future, launching a new study of the device in the U.S. this week.

But can the Prodigy device -- and St. Jude's neuromodulation business -- help restore growth to this cardiovascular giant? Fool contributor Dan Carroll tells you all you need to know in the video below, and explains how tough competition from the likes of Medtronic (NYSE: MDT  ) and Stryker (NYSE: SYK  ) will weigh on St. Jude's neuromodulation push.

The growth opportunity that could light the market on fire
St. Jude has been a big winner this year for investors despite its financial slump, but there's one incredible stock that's not only beating St. Jude's gains, but boasts of a potential that every investor needs to know. This tech stock is growing twice as fast as Google and Facebook, and more than three times as fast as and Apple. Watch our jaw-dropping investor alert video today to find out why The Motley Fool's chief technology officer is putting $117,238 of his own money on the table, and why he's so confident this will be a huge winner in 2013 and beyond. Just click here to watch!

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2755009, ~/Articles/ArticleHandler.aspx, 9/26/2016 12:12:18 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/23/2016 4:02 PM
STJ $79.64 Up +0.03 +0.04%
St. Jude Medical CAPS Rating: **
MDT $87.71 Down -0.11 -0.13%
Medtronic CAPS Rating: *****
SYK $117.76 Down -0.68 -0.57%
Stryker CAPS Rating: *****